Bravecto 112mg For Very Small Dogs 2-4kg (4.4-8.8lbs)

Bravecto (Orange) 112.mg Chewable Tablet for dogs and puppies from 8 week old weighing 2- 4.5 Kg (2.2lbs - 8.8lbs)
Up to 12-week protection against fleas and ticks in an oral chew.
The active substance of Bravecto, fluralaner, a new ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks (black legged tick, American dog tick, and brown dog tick), delivering protection for up to 12 full weeks. It also kills lone star ticks for eight weeks. Presented in a highly palatable flavored chew that dogs accept readily.

Advantages

• Consistent, broad-spectrum and long-lasting efficacy against both fleas and ticks
• Rapid onset of action and speed of kill
• Maximizes owner compliance while reducing protection gaps that can occur with monthly remedies

IMPORTANT SAFETY INFORMATION:
The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against lone star ticks beyond 8 weeks after dosing.


Bravecto (Orange) 112.mg Chewable Tablet for dogs and puppies from 8 week old weighing 2- 4.5 Kg (2.2lbs - 8.8lbs)
Up to 12-week protection against fleas and ticks in an oral chew.
The active substance of Bravecto, fluralaner, a new ectoparasiticide belonging to the isoxazoline group, is systemically active against fleas and ticks (black legged tick, American dog tick, and brown dog tick), delivering protection for up to 12 full weeks. It also kills lone star ticks for eight weeks. Presented in a highly palatable flavored chew that dogs accept readily.

Advantages

• Consistent, broad-spectrum and long-lasting efficacy against both fleas and ticks
• Rapid onset of action and speed of kill
• Maximizes owner compliance while reducing protection gaps that can occur with monthly remedies

IMPORTANT SAFETY INFORMATION:
The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against lone star ticks beyond 8 weeks after dosing.